Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4202]

ESMO 2024: Breastfeeding after breast cancer is safe

ESMO 2024: Breastfeeding after breast cancer is safe

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer

ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer

Genes with strong impact on menopause timing also link to cancer risk

Genes with strong impact on menopause timing also link to cancer risk

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

Shorter-course radiation better option for breast cancer patients than conventional schedule

Shorter-course radiation better option for breast cancer patients than conventional schedule

NCCN Policy Summit explores how to build an inclusive cancer center workplace culture that better serves everybody

NCCN Policy Summit explores how to build an inclusive cancer center workplace culture that better serves everybody

Chemical screen identifies PRMT5 as therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer

Chemical screen identifies PRMT5 as therapeutic vulnerability for paclitaxel-resistant triple-negative breast...

Double trouble for triple-negative breast cancer

Double trouble for triple-negative breast cancer

Scientists identify potential new immune system target to head off the spread of breast cancer cells

Scientists identify potential new immune system target to head off the spread of breast cancer cells

More from ecancer